{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:28:33Z","timestamp":1792790913932,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["21K15602"],"award-info":[{"award-number":["21K15602"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Takeda Science Foundation 2021","id":[{"id":"https:\/\/ror.org\/02y123g31","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Research Grant for Public Health Science"},{"name":"The Japan Society of Gynecologic Oncology 2022"},{"name":"Nihon University Research Grant for 2024","id":[{"id":"https:\/\/ror.org\/05jk51a88","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71606-w","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T08:02:35Z","timestamp":1725609755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum levels of stearic and dihomo-\u03b3-linolenic acids can be used to diagnose cervical cancer and cervical intraepithelial neoplasia"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7467-3377","authenticated-orcid":false,"given":"Yuki","family":"Katoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Sugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanoko","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Udagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kawana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"71606_CR1","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/ijc.27485","volume":"131","author":"P Guan","year":"2012","unstructured":"Guan, P. et al. Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer. Int. J. Cancer 131, 2349\u20132359. https:\/\/doi.org\/10.1002\/ijc.27485 (2012).","journal-title":"Int. J. Cancer"},{"key":"71606_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.15366","author":"S Sabeena","year":"2024","unstructured":"Sabeena, S., Ravishankar, N. & Kalpana, M. M. Implementation strategies of cervical cancer screening in South Asia: A systematic review. Int. J. Gynaecol. Obstet. https:\/\/doi.org\/10.1002\/ijgo.15366 (2024).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"71606_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.gore.2017.12.005","volume":"24","author":"M Swanson","year":"2018","unstructured":"Swanson, M. et al. Evidence-based improvisation: Facing the challenges of cervical cancer care in Uganda. Gynecol. Oncol. Rep. 24, 30\u201335. https:\/\/doi.org\/10.1016\/j.gore.2017.12.005 (2018).","journal-title":"Gynecol. Oncol. Rep."},{"key":"71606_CR4","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3892\/ol.2020.11754","volume":"20","author":"R Hull","year":"2020","unstructured":"Hull, R. et al. Cervical cancer in low and middle-income countries. Oncol. Lett. 20, 2058\u20132074. https:\/\/doi.org\/10.3892\/ol.2020.11754 (2020).","journal-title":"Oncol. Lett."},{"key":"71606_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"71606_CR6","doi-asserted-by":"publisher","first-page":"e1115","DOI":"10.1016\/s2214-109x(22)00241-8","volume":"10","author":"L Bruni","year":"2022","unstructured":"Bruni, L. et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob. Health 10, e1115\u2013e1127. https:\/\/doi.org\/10.1016\/s2214-109x(22)00241-8 (2022).","journal-title":"Lancet Glob. Health"},{"issue":"Suppl 1","key":"71606_CR7","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/s0020-7292(06)60030-1","volume":"95","author":"MA Quinn","year":"2006","unstructured":"Quinn, M. A. et al. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int. J. Gynaecol. Obstet. 95(Suppl 1), S43-103. https:\/\/doi.org\/10.1016\/s0020-7292(06)60030-1 (2006).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"71606_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ygyno.2018.03.056","volume":"150","author":"C Charakorn","year":"2018","unstructured":"Charakorn, C. et al. The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis. Gynecol. Oncol. 150, 190\u2013200. https:\/\/doi.org\/10.1016\/j.ygyno.2018.03.056 (2018).","journal-title":"Gynecol. Oncol."},{"key":"71606_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkad101","author":"K Kawana","year":"2023","unstructured":"Kawana, K. et al. Phase I and II randomized clinical trial of an oral therapeutic vaccine targeting human papillomavirus for treatment of cervical intraepithelial neoplasia 2 and 3. JNCI Cancer Spectr. https:\/\/doi.org\/10.1093\/jncics\/pkad101 (2023).","journal-title":"JNCI Cancer Spectr."},{"key":"71606_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/grf.0000000000000507","volume":"63","author":"EK Hill","year":"2020","unstructured":"Hill, E. K. Updates in cervical cancer treatment. Clin. Obstet. Gynecol. 63, 3\u201311. https:\/\/doi.org\/10.1097\/grf.0000000000000507 (2020).","journal-title":"Clin. Obstet. Gynecol."},{"key":"71606_CR11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/modpathol.2013.166","volume":"27","author":"LF Escobar-Hoyos","year":"2014","unstructured":"Escobar-Hoyos, L. F. et al. Keratin 17 in premalignant and malignant squamous lesions of the cervix: Proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker. Mod. Pathol. 27, 621\u2013630. https:\/\/doi.org\/10.1038\/modpathol.2013.166 (2014).","journal-title":"Mod. Pathol."},{"key":"71606_CR12","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/cam4.3799","volume":"10","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. Discovery and validation of novel biomarkers for detection of cervical cancer. Cancer Med. 10, 2063\u20132074. https:\/\/doi.org\/10.1002\/cam4.3799 (2021).","journal-title":"Cancer Med."},{"key":"71606_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2217\/bmm-2020-0629","volume":"15","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. ANXA2 is a potential marker for the diagnosis of human cervical cancer. Biomark Med. 15, 57\u201367. https:\/\/doi.org\/10.2217\/bmm-2020-0629 (2021).","journal-title":"Biomark Med."},{"key":"71606_CR14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/pgp.0000000000000677","volume":"40","author":"GH Han","year":"2021","unstructured":"Han, G. H. et al. The combination of transient receptor potential vanilloid type 1 (TRPV1) and phosphatase and tension homolog (PTEN) is an effective prognostic biomarker in cervical cancer. Int. J. Gynecol. Pathol. 40, 214\u2013223. https:\/\/doi.org\/10.1097\/pgp.0000000000000677 (2021).","journal-title":"Int. J. Gynecol. Pathol."},{"key":"71606_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/1476-4598-9-167","volume":"9","author":"SM Wilting","year":"2010","unstructured":"Wilting, S. M. et al. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol. Cancer 9, 167. https:\/\/doi.org\/10.1186\/1476-4598-9-167 (2010).","journal-title":"Mol. Cancer"},{"key":"71606_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4161\/epi.23605","volume":"8","author":"SM Wilting","year":"2013","unstructured":"Wilting, S. M. et al. Methylation-mediated transcriptional repression of microRNAs during cervical carcinogenesis. Epigenetics 8, 220\u2013228. https:\/\/doi.org\/10.4161\/epi.23605 (2013).","journal-title":"Epigenetics"},{"key":"71606_CR17","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1158\/1078-0432.Ccr-21-3710","volume":"28","author":"R van den Helder","year":"2022","unstructured":"van den Helder, R. et al. HPV and DNA methylation testing in urine for cervical intraepithelial neoplasia and cervical cancer detection. Clin. Cancer Res. 28, 2061\u20132068. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-3710 (2022).","journal-title":"Clin. Cancer Res."},{"key":"71606_CR18","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1158\/1078-0432.Ccr-22-2263","volume":"29","author":"S Halford","year":"2023","unstructured":"Halford, S. et al. A phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer. Clin. Cancer Res. 29, 1429\u20131439. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-2263 (2023).","journal-title":"Clin. Cancer Res."},{"key":"71606_CR19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.cmet.2017.08.017","volume":"26","author":"MV Liberti","year":"2017","unstructured":"Liberti, M. V. et al. A predictive model for selective targeting of the warburg effect through GAPDH inhibition with a natural product. Cell. Metab. 26, 648-659.e648. https:\/\/doi.org\/10.1016\/j.cmet.2017.08.017 (2017).","journal-title":"Cell. Metab."},{"key":"71606_CR20","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.bbcan.2018.04.009","volume":"2\u201314","author":"AK Kaushik","year":"1870","unstructured":"Kaushik, A. K. & DeBerardinis, R. J. Applications of metabolomics to study cancer metabolism. Biochim. Biophys. Acta Rev. Cancer 2\u201314, 2018. https:\/\/doi.org\/10.1016\/j.bbcan.2018.04.009 (1870).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"71606_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cmet.2018.06.003","volume":"28","author":"A Daemen","year":"2018","unstructured":"Daemen, A. et al. Pan-cancer metabolic signature predicts co-dependency on glutaminase and de novo glutathione synthesis linked to a high-mesenchymal cell state. Cell. Metab. 28, 383-399.e389. https:\/\/doi.org\/10.1016\/j.cmet.2018.06.003 (2018).","journal-title":"Cell. Metab."},{"key":"71606_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004616","author":"Y Katoh","year":"2022","unstructured":"Katoh, Y. et al. Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating \u03b2-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody. J. Immunother. Cancer https:\/\/doi.org\/10.1136\/jitc-2022-004616 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"71606_CR23","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1158\/2767-9764.Crc-23-0138","volume":"3","author":"K Katoh","year":"2023","unstructured":"Katoh, K. et al. Serum free fatty acid changes caused by high expression of stearoyl-CoA desaturase 1 in tumor tissues are early diagnostic markers for ovarian cancer. Cancer Res. Commun. 3, 1840\u20131852. https:\/\/doi.org\/10.1158\/2767-9764.Crc-23-0138 (2023).","journal-title":"Cancer Res. Commun."},{"key":"71606_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3892\/mco.2016.875","volume":"5","author":"Y Nagamitsu","year":"2016","unstructured":"Nagamitsu, Y. et al. Profiling analysis of circulating microRNA expression in cervical cancer. Mol. Clin. Oncol. 5, 189\u2013194. https:\/\/doi.org\/10.3892\/mco.2016.875 (2016).","journal-title":"Mol. Clin. Oncol."},{"key":"71606_CR25","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/s2214-109x(22)00501-0","volume":"11","author":"D Singh","year":"2023","unstructured":"Singh, D. et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob. Health 11, e197\u2013e206. https:\/\/doi.org\/10.1016\/s2214-109x(22)00501-0 (2023).","journal-title":"Lancet Glob. Health"},{"key":"71606_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/s1470-2045(18)30836-2","volume":"20","author":"KT Simms","year":"2019","unstructured":"Simms, K. T. et al. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020\u201399: a modelling study. Lancet Oncol. 20, 394\u2013407. https:\/\/doi.org\/10.1016\/s1470-2045(18)30836-2 (2019).","journal-title":"Lancet Oncol."},{"key":"71606_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/bjc.2017.371","volume":"118","author":"JUH Lam","year":"2018","unstructured":"Lam, J. U. H. et al. High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders. Br. J. Cancer 118, 138\u2013144. https:\/\/doi.org\/10.1038\/bjc.2017.371 (2018).","journal-title":"Br. J. Cancer"},{"key":"71606_CR28","doi-asserted-by":"publisher","first-page":"23726","DOI":"10.18632\/aging.203645","volume":"13","author":"Y Lai","year":"2021","unstructured":"Lai, Y. et al. Exosome long non-coding RNA SOX2-OT contributes to ovarian cancer malignant progression by miR-181b-5p\/SCD1 signaling. Aging (Albany NY) 13, 23726\u201323738. https:\/\/doi.org\/10.18632\/aging.203645 (2021).","journal-title":"Aging (Albany NY)"},{"key":"71606_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102890","author":"S Cruz-Gil","year":"2020","unstructured":"Cruz-Gil, S., Fern\u00e1ndez, L. P., S\u00e1nchez-Mart\u00ednez, R., G\u00f3mez de Cedr\u00f3n, M. & Ram\u00edrez de Molina, A. Non-coding and regulatory RNAs as epigenetic remodelers of fatty acid homeostasis in cancer. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers12102890 (2020).","journal-title":"Cancers (Basel)"},{"key":"71606_CR30","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/s2214-109x(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn, M. et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob. Health 8, e191\u2013e203. https:\/\/doi.org\/10.1016\/s2214-109x(19)30482-6 (2020).","journal-title":"Lancet Glob. Health"},{"key":"71606_CR31","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/ijc.30901","volume":"141","author":"S Vaccarella","year":"2017","unstructured":"Vaccarella, S., Laversanne, M., Ferlay, J. & Bray, F. Cervical cancer in Africa, Latin America and the Caribbean and Asia: Regional inequalities and changing trends. Int. J. Cancer 141, 1997\u20132001. https:\/\/doi.org\/10.1002\/ijc.30901 (2017).","journal-title":"Int. J. Cancer"},{"key":"71606_CR32","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s11306-014-0628-z","volume":"10","author":"A Koulman","year":"2014","unstructured":"Koulman, A. et al. The development and validation of a fast and robust dried blood spot based lipid profiling method to study infant metabolism. Metabolomics 10, 1018\u20131025. https:\/\/doi.org\/10.1007\/s11306-014-0628-z (2014).","journal-title":"Metabolomics"},{"issue":"Suppl 2","key":"71606_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ijgo.12611","volume":"143","author":"N Bhatla","year":"2018","unstructured":"Bhatla, N., Aoki, D., Sharma, D. N. & Sankaranarayanan, R. Cancer of the cervix uteri. Int. J. Gynaecol. Obstet. 143(Suppl 2), 22\u201336. https:\/\/doi.org\/10.1002\/ijgo.12611 (2018).","journal-title":"Int. J. Gynaecol. Obstet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71606-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71606-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71606-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T08:11:06Z","timestamp":1725610266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71606-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71606"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71606-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted according to the guidelines of the Declaration of Helsinki and was approved by the Nihon University Institutional Review Board (RK-170711\u20136, approved on 25 August 2017; RK-200609\u20131, approved on 9 September 2020) and Keio University Institutional Review Board (20110159, approved on 26 September 2011; 20130122 approved on 7 August 2013). Written informed consent was obtained from patients for the use of clinical materials for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"20833"}}